Explore Stanford technologies available for licensing:

Researchers at Stanford Genome Technology Center have patented a highly sensitive and specific straightforward circular Proximity Ligation Assay (c-PLA) method to reduce background and improve quantitative detection of protein biomarkers through conversion into unique DNA sequ

Single-cell analysis in living humans is difficult for non-regenerative organs like the eye and brain due to biopsy damage.

Stanford scientists have discovered that certain immune receptors become more active in hematopoietic stem cells with age. This change leads to increased production of myeloid cells in the bone marrow.

Researchers in the Bao Group demonstrated a first in class, stretchable, high performance, high transistor density device.

Stanford scientists have developed novel polyacrylamide-based copolymers that exhibit antimicrobial activity against both Gram-negative and Gram-positive bacteria through a membrane disruption mechanism.

Stanford researchers in the Cargnello Lab have developed a new energy efficient method of converting lithium precursors, such as lithium chloride or lithium sulfate, to battery-ready lithium products, such as lithium hydroxide or lithium carbonate.

Researchers at Stanford University have found that recombinant osteopontin (SPP1) protein reduces foreign body response (FBR) and thereby facilitates successful integration and function of implantable devices.

Stanford researchers have developed a novel approach to ultrasound imaging using the differentiable beamforming pipeline, which optimizes critical imaging parameters, significantly enhancing image quality and diagnostic accuracy in ultrasound imaging.

Researchers at Stanford have developed a fluorescent dye to enable noninvasive, fast, cost-effective, and specific imaging of bacterial infections.

Stanford researchers at the de la Zerda Lab have developed an innovative alignment methodology using Optical Coherence Tomography (OCT) in conjunction with histopathology to diagnose cancer or determine tumor margins.

Researchers at Stanford have developed a novel method for the isolation of neural stem and progenitor cells (NSPCs).

Stanford researchers have developed AZD7648, a novel DNA-PK inhibitor that enhances HDR efficiency in CRISPR-Cas9 gene editing by shifting DNA repair from the error-prone NHEJ pathway to the precise HDR pathway, significantly improving gene targeting outcomes in human cells fo

Elastin-like polypeptides (ELPs) are promising biomaterials for medical applications due to their non-immunogenicity, scalable synthesis, and tunable self-assembly.

The lack of effective treatments for myocardial ischemia and reperfusion injury has been a major challenge in decreasing mortality rates from myocardial infarctions. Stromal cell-derived factor-1?

Stanford scientists have developed a new protocol for perturb-seq that is significantly cheaper and more efficient than existing approaches.